Peter Zdziarski/LinkedIn
Mar 14, 2026, 13:24
Peter Zdziarski: Robotic Hysterectomy Brings Hope for Glanzmann Thrombasthenia Patients
Peter Zdziarski, Founder and Marketing Director of Glanzmann Thrombasthenia Advocacy Network, shared a post on LinkedIn:
“For people living with Glanzmann Thrombasthenia, surgery can be extremely high-risk due to the potential for severe bleeding.
That is why this case matters.
Doctors at Apollo Hospitals Navi Mumbai successfully performed a robotic hysterectomy on a patient with GT, showing how careful planning and advanced surgical techniques can make complex procedures possible.
Progress like this gives real hope to the rare bleeding disorder community.”
Stay updated with Hemostasis Today.
-
Mar 14, 2026, 12:59Giuseppe Lippi: New Highlights on Key Aspects of Heparin Anticoagulant Therapy and Monitoring
-
Mar 14, 2026, 12:39Samwel Mikaye: Blood Smear Morphology Guide
-
Mar 14, 2026, 12:24Pradeep Natarajan: Key New Aspects of the 2026 ACC/AHA Dyslipidemia Guidelines
-
Mar 13, 2026, 22:57Robert Hamilton: The Reality of Stroke Care and Why 81.6% Should be a Wake-Up call
-
Mar 13, 2026, 22:05Christoph B. Olivier: Annabel Hölzle Shared Critical Findings on HALT After TAVR
-
Mar 13, 2026, 21:29Timothy Glidewell: Genetic Signals of Platelet and Clotting Pathways in Cryptogenic Stroke
-
Mar 13, 2026, 21:19New Canadian Insights on Switching to Longer-Acting Therapy for Hemophilia A – WFH
-
Mar 13, 2026, 21:01Leonardo Roever: Brain Age as a Biomarker of Neuroplasticity and Motor Recovery After Stroke
-
Mar 13, 2026, 20:50William Tembo: Understanding Stroke Through Landmark Clinical Trials